Microbiota-Derived Indole-3-Propionic Acid in Autism Spectrum Disorder: From Metabolic Associations to Neural Functional Responses

Abnormalities in neural circuit organization and synaptic function are implicated in autism spectrum disorder (ASD), but the relevance of gut microbial metabolites to these alterations remains unclear. Indole-3-propionic acid (IPA), a microbial tryptophan metabolite capable of reaching the central nervous system, provides a potential link between intestinal metabolism and ASD-related neural function. Human studies report heterogeneous IPA profiles, including associations with selected neurobehavioral phenotypes and inconsistent differences between diagnostic groups. In ASD-related experimental models, IPA supplementation modifies glial activity, synaptic organization, GABAergic neurotransmission, and behavioral outcomes, whereas a broader microbiota intervention improved ASD-like behavior despite reduced IPA levels. This Mini-Review integrates these findings with evidence concerning IPA production, neural exposure, host sensing, and synaptic regulation. By distinguishing metabolic association, functional responsiveness, and causal pathway dependence, this review clarifies the biological relevance of IPA to ASD and identifies the mechanistic relationships requiring further investigation.

Authors

Institutions

Publication Details

Published
2026-11-19
DOI
https://doi.org/10.20517/scierxiv202611.1033.v1
Primary Topic
Autism Spectrum Disorder Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Microbiota-Derived Indole-3-Propionic Acid in Autism Spectrum Disorder: From Metabolic Associations to Neural Functional Responses

Hanan Song, Sichen Zhou, Weihao Shi, Yuxiong Xu et al.
3 links
Autism Spectrum Disorder Research
preprint

Microbiota-Derived Indole-3-Propionic Acid in Autism Spectrum Disorder: From Metabolic Associations to Neural Functional Responses

Hanan Song, Sichen Zhou, Weihao Shi, Yuxiong Xu, Yanli Yu, Yizhuo Yang
preprint en

Abstract

Abnormalities in neural circuit organization and synaptic function are implicated in autism spectrum disorder (ASD), but the relevance of gut microbial metabolites to these alterations remains unclear. Indole-3-propionic acid (IPA), a microbial tryptophan metabolite capable of reaching the central nervous system, provides a potential link between intestinal metabolism and ASD-related neural function. Human studies report heterogeneous IPA profiles, including associations with selected neurobehavioral phenotypes and inconsistent differences between diagnostic groups. In ASD-related experimental models, IPA supplementation modifies glial activity, synaptic organization, GABAergic neurotransmission, and behavioral outcomes, whereas a broader microbiota intervention improved ASD-like behavior despite reduced IPA levels. This Mini-Review integrates these findings with evidence concerning IPA production, neural exposure, host sensing, and synaptic regulation. By distinguishing metabolic association, functional responsiveness, and causal pathway dependence, this review clarifies the biological relevance of IPA to ASD and identifies the mechanistic relationships requiring further investigation.

Capital University of Physical Education and Sports (CN)
Good health and well-being
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon